시장보고서

상품코드

1606431

연속 글루코오스 모니터링 시장 : 컴포넌트 유형별, 모달리티별, 제품 유형별, 환자 유형별, 유통 채널별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Continuous Glucose Monitoring Market, By Component Type, By Modality, By Product Type, By Patient Type, By Distribution Channel, By Country, and By Region -Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 11월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 284 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

연속 글루코오스 모니터링 시장 규모는 2023년에 113억 2,932만 달러에 달하며, 2024-2032년 CAGR 12.79%로 확대

연속 글루코오스 모니터링 시장 - 시장 역학

비침습적 글루코오스 모니터링 기술은 보다 쾌적하고 편리한 대안을 제공합니다.

비침습적 포도당 모니터링 기술은 기존의 핑거스틱 검사에 비해 더 편안하고 편리한 대안을 제공할 수 있는 잠재력을 가지고 있으며, 성장세를 보이고 있습니다. 지속적 포도당 모니터링 시장의 주요 촉진요인으로는 바이오센서 기술의 발전으로 피부 침투 없이도 보다 정확하고 신뢰할 수 있는 측정이 가능해졌습니다는 점을 들 수 있습니다. 땀, 눈물, 적외선 모니터링과 같은 비침습적 방법은 불편함과 감염 위험을 줄여주기 때문에 잦은 모니터링이 필요한 환자들에게 매력적입니다. 또한 당뇨병 환자와 의료 서비스 프로바이더 사이에서 통증이 없고 사용하기 쉬운 장비를 선호하는 경향이 증가하고 있는 점도 채택에 박차를 가하고 있습니다.

비침습적 기술은 또한 당뇨병 발병 위험이 있는 환자를 포함하여 더 많은 사용자에게 혈당 모니터링의 매력을 확대할 것으로 예상됩니다. 이러한 시스템의 편의성은 환자의 순응도를 높이고 전반적인 질병 관리를 강화할 수 있습니다. 미국 국립보건원(NIH)에 따르면 미국 성인 3명 중 1명은 당뇨병 발병 위험이 있는 것으로 추정되며, 이는 보다 접근성이 높고 덜 침습적인 모니터링 솔루션에 대한 수요를 더욱 증가시키고 있습니다. 비침습적 기술에 대한 정부 및 학계의 지원이 증가함에 따라 당뇨병 관리를 위한 보다 혁신적인 솔루션을 연구하는 연구자들로 인해 시장은 성장할 준비가 되어 있습니다.

지속적 포도당 모니터링 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면 세계 시장은 예측 기간(2024-2032) 동안 매년 약 12.79%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

부품 유형별로는 센서가 2023년 주요 부문으로 부상할 것으로 예상됩니다.

2023년에는 침습성이 가장 큰 비중을 차지할 것으로 예상됩니다.

제품 유형별로는 연속 혈당 모니터링 시스템(CGMS)이 2023년에 가장 높은 시장 점유율을 보였습니다.

환자 유형별로는 2023년 1형 당뇨병이 가장 큰 비중을 차지할 것으로 보입니다.

유통 채널별로는 2023년 소매 판매가 주요 부문으로 부상했습니다.

지역별로는 북미가 2023년 주요 수입원이 될 것으로 예상됩니다.

지속혈당 모니터링 시장 - 세분화 분석 :

지속적 포도당 모니터링 세계 시장은 컴포넌트 유형, 양식, 제품 유형, 환자 유형, 유통 채널 및 지역을 기준으로 세분화됩니다.

시장은 제품 유형에 따라 연속 혈당 모니터링 시스템(CGMS)과 자가 혈당 측정 시스템(SMBG)의 두 가지로 분류됩니다. 연속 혈당 모니터링 시스템(CGMS) 시장에서는 웨어러블 CGMS, 특히 센서 기반 장비가 지배적인 부문입니다. 이러한 시스템은 실시간 지속적인 포도당 데이터를 제공하여 당뇨병 환자, 특히 제 1형 당뇨병 환자에게 큰 이점을 제공합니다. 보다 정확하고, 사용하기 쉽고, 덜 침습적인 솔루션에 대한 수요가 증가하면서 웨어러블 CGMS의 채택을 촉진하고 있습니다. 웨어러블 CGMS는 스마트폰 및 인슐린 펌프와 통합하여 자동 데이터 추적 및 관리를 할 수 있습니다. 이 기술은 환자의 편의성을 향상시킬 뿐만 아니라 혈당 조절을 개선할 수 있으며, 시장 성장의 주요 동력이 되고 있습니다.

시장은 양식에 따라 침습적 CGM과 비침습적 CGM의 두 가지 범주로 나뉩니다. 침습적 연속 혈당 모니터링(CGM) 시스템은 시장에서 가장 지배적인 부문입니다. 이 시스템에는 포도당 수치를 실시간으로 지속적으로 모니터링하고 정확하고 신뢰할 수 있는 데이터를 제공하는 피하 센서가 포함되어 있습니다. 저혈당 및 고혈당 경고, 인슐린 펌프 및 스마트폰과의 통합과 같은 주요 기능을 제공합니다. 침습적 CGM의 장점은 입증된 정확성, 광범위한 규제 당국의 승인, 주요 제조업체의 강력한 시장 입지를 기반으로 하고 있습니다. 비침습적 시스템의 발전에도 불구하고 침습적 CGM은 여전히 당뇨병을 효과적으로 관리하기 위해 선호되는 선택입니다.

지속적 포도당 모니터링 시장 - 지역적 인사이트

북미의 연속 혈당 모니터링(CGM) 시장은 당뇨병 유병률 증가와 혈당 관리의 중요성에 대한 인식이 높아짐에 따라 빠르게 성장하고 있습니다. 미국이 가장 큰 시장 점유율을 차지하고 있으며, 제1형 및 2형 당뇨병 환자 모두 실시간 데이터 제공, 혈당 조절 개선, 합병증 감소 등의 기능으로 인해 CGM 시스템 채택을 늘리고 있습니다. 또한 소형화, 저가화, 사용 편의성 향상 등의 기술 발전도 시장 성장을 가속하고 있습니다. 모바일 앱 및 기타 디지털 건강 솔루션과의 통합은 CGM 기기의 매력을 더욱 높이고 있습니다. 또한 당뇨병 관련 합병증 유병률 증가와 예방적 건강관리 증가는 CGM 시스템에 대한 강력한 수요를 창출하고 있으며, FDA와 같은 기관의 규제 승인과 유리한 상환 정책은 채택을 더욱 가속화하고 있습니다. 헬스케어 시스템이 만성질환 관리와 개인맞춤형 의료를 우선시함에 따라 미국과 캐나다 모두에서 시장이 지속적으로 성장할 것으로 예상됩니다.

지속혈당 모니터링 시장 - 경쟁 구도:

연속 혈당 모니터링(CGM) 시장 경쟁 구도는 기존 기업과 혁신적인 당뇨병 관리 솔루션에 주력하는 신생 기업이 혼재되어 있으며, Abbott, Dexcom, Medtronic과 같은 주요 기업이 실시간 혈당 모니터링, Abbott의 FreeStyle Libre와 Dexcom의 G6/G7 시스템이 가장 널리 사용되고 있으며, 메드트로닉도 가디아와 함께 인슐린 펌프와의 통합, 모바일 앱과의 연동을 제공하는 첨단 CGM 시스템으로 시장을 주도하고 있습니다. Medtronic도 Guardian Connect 시스템으로 강력한 입지를 유지하고 있습니다. 이식형 Eversense CGM의 Senseonics와 같은 신규 시장 진출기업은 더 긴 센서 수명을 제공하는 독특한 솔루션을 시장에 제공합니다. CGM 제조업체와 인슐린 공급업체, 모바일 건강 앱과 같은 제약회사 및 하이테크 기업과의 제휴는 경쟁을 더욱 치열하게 하고, 시장의 혁신과 성장을 가속하고 있습니다. 또한 규제 당국의 승인 및 상환 정책은 경쟁의 역학을 형성하는 데 매우 중요합니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제13장 주요 벤더 분석 - 연속 글루코오스 모니터링 업계

경쟁 대시보드
- Competitive Benchmarking
- Competitive Positioning
기업 개요
- Abbott Laboratories
- Dexcom, Inc.
- Medtronic plc
- Senseonics Holdings, Inc.
- Roche Diagnostics
- LifeScan, Inc.
- Ascensia Diabetes Care
- Tandem Diabetes Care, Inc.
- Insulet Corporation
- Ypsomed Holding AG
- Johnson &Johnson
- GlucoWise
- Beta Bionics
- Pear Therapeutics
- Diasend
- F. Hoffmann-La Roche AG
- Novo Nordisk A/S
- Glooko, Inc.

제14장 애널리스트의 전방위 전망

KSA 24.12.24

REPORT HIGHLIGHT

Continuous Glucose Monitoring Market size was valued at USD 11,329.32 Million in 2023, expanding at a CAGR of 12.79% from 2024 to 2032.

The Continuous Glucose Monitoring (CGM) market refers to the sector that develops and supplies devices designed to track glucose levels in real-time throughout the day and night. These devices are primarily used by individuals with diabetes to manage their blood sugar levels more effectively, reducing the need for frequent fingerstick testing. CGMs work by using a sensor placed under the skin to measure glucose in the interstitial fluid, transmitting data to a receiver or smartphone. The market has seen significant growth due to rising diabetes prevalence, increasing awareness about diabetes management, and technological advancements that have made CGMs more accurate, affordable, and user-friendly. CGMs also offer features like alerts for hypo- or hyperglycemia and integration with insulin pumps, providing enhanced control. As healthcare systems emphasize preventative care, the demand for CGMs is expected to continue rising, creating opportunities for innovation and expansion in the market.

Continuous Glucose Monitoring Market- Market Dynamics

Non-invasive glucose monitoring technologies offer more comfortable, convenient alternatives.

Non-invasive glucose monitoring technologies are gaining momentum due to their potential to offer more comfortable, convenient alternatives to traditional fingerstick testing. Key drivers for the Continuous Glucose Monitoring Market include advancements in biosensor technology, which are enabling more accurate and reliable measurements without the need for skin penetration. Non-invasive methods, such as monitoring through sweat, tears, or infrared light, reduce discomfort and the risk of infection, which appeals to patients who require frequent monitoring. Furthermore, the growing preference for painless, user-friendly devices among diabetic patients and healthcare providers is fueling adoption.

Non-invasive technologies also promise to broaden the appeal of glucose monitoring to a wider range of users, including those at risk of developing diabetes. The convenience of these systems can improve patient compliance and enhance overall disease management. According to the National Institutes of Health (NIH), an estimated 1 in 3 American adults is at risk of developing diabetes, further driving the demand for more accessible and less invasive monitoring solutions. With increasing government and academic support for non-invasive technologies, the market is poised for growth as researchers explore more innovative solutions for diabetes management.

Continuous Glucose Monitoring Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.79% over the forecast period (2024-2032)

Based on Component Type segmentation, Sensors was the leading segment in 2023

Based on Modality segmentation, Invasive was the leading segment in 2023

Based on Product Type segmentation, Continuous Glucose Monitoring Systems (CGMS) was predicted to show maximum market share in the year 2023

Based on Patient Type segmentation, Type 1 diabetes was the leading segment in 2023

Based on Distribution Channel segmentation, Retail Sales was the leading segment in 2023

based on Region, North America was the leading revenue generator in 2023

Continuous Glucose Monitoring Market- Segmentation Analysis:

The Global Continuous Glucose Monitoring Market is segmented based on Component Type, Modality, Product Type, Patient Type, Distribution Channel, and Region.

The market is divided into two categories based on Product Type: Continuous Glucose Monitoring Systems (CGMS) and Self-Monitoring Blood Glucose Systems (SMBG). In the Continuous Glucose Monitoring Systems (CGMS) market, the dominant segment is the wearable CGMS, particularly the sensor-based devices. These systems provide real-time, continuous glucose data, offering significant benefits for patients with diabetes, especially those with Type 1 diabetes. The growing demand for more accurate, user-friendly, and minimally invasive solutions has driven the adoption of wearable CGMS, which can be integrated with smartphones or insulin pumps for automated data tracking and management. This technology not only enhances patient convenience but also improves glycemic control, making it a key driver in the market's growth.

The market is divided into two categories based on Modality: Invasive CGM and Non-Invasive CGM. Invasive Continuous Glucose Monitoring (CGM) systems are the most dominant segment in the market. These systems involve a subcutaneous sensor that continuously monitors glucose levels in real time, providing accurate and reliable data. They offer key features such as alerts for hypo- or hyperglycemia, and integration with insulin pumps and smartphones. The dominance of invasive CGMs is due to their proven accuracy, extensive regulatory approvals, and strong market presence from leading manufacturers. Despite the ongoing development of non-invasive systems, invasive CGMs remain the preferred choice for managing diabetes effectively.

Continuous Glucose Monitoring Market- Geographical Insights

The North American landscape for the Continuous Glucose Monitoring (CGM) market is rapidly expanding, driven by rising incidences of diabetes and increasing awareness about the importance of glucose management. The U.S. holds the largest share, with both Type 1 and Type 2 diabetes patients increasingly adopting CGM systems due to their ability to provide real-time data, improve glycemic control, and reduce complications. Advancements in technology, such as smaller, more affordable, and user-friendly devices, are also fueling market growth. The integration of CGM devices with mobile apps and other digital health solutions is further enhancing their appeal. Moreover, the growing prevalence of diabetes-related complications, coupled with the push for preventive healthcare, is creating a strong demand for CGM systems. Regulatory approvals from bodies like the FDA and favorable reimbursement policies are further accelerating adoption. As healthcare systems prioritize chronic disease management and personalized medicine, the market is expected to see continued growth in both the U.S. and Canada.

Continuous Glucose Monitoring Market- Competitive Landscape:

The competitive landscape of the Continuous Glucose Monitoring (CGM) market is characterized by a mix of established players and emerging companies focused on innovative diabetes management solutions. Leading companies like Abbott, Dexcom, and Medtronic dominate the market, with their advanced CGM systems offering real-time glucose monitoring, integration with insulin pumps, and mobile app connectivity. Abbott's FreeStyle Libre and Dexcom's G6/G7 systems are among the most widely used. Medtronic also maintains a strong position with its Guardian Connect system. Newer entrants like Senseonics, with its implantable Eversense CGM, bring unique solutions to the market, offering longer sensor life. The market is highly competitive with companies competing on factors like sensor accuracy, ease of use, pricing, and patient data management capabilities. Partnerships between CGM manufacturers and pharmaceutical or tech companies, such as insulin providers or mobile health apps, further intensify competition, driving innovation and growth in the market. Furthermore, regulatory approval and reimbursement policies are crucial in shaping the competitive dynamics.

Recent Developments:

In February 2024, Dexcom, Inc. introduces Dexcom ONE+, the latest Continuous Glucose Monitoring (CGM), to strengthen strong, new diabetes care technologies for patients in Belgium, Spain, and Poland.

In January 2024, Abbott and Tandem Diabetes Care, Inc., a player in insulin delivery and diabetes technologies, unveiled the t: slim X2 insulin pump with Control-IQ technology, making it the first automated insulin administration system in the United States to combine with the FreeStyle Libre 2 Plus sensor. This enabled the organization to strengthen its product portfolio.

In January 2024, Medtronic got CE approval for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one Continuous Glucose Monitor (CGM) that does not require fingersticks or overtape, to strengthen its product line. to bring

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
Dexcom, Inc.
Medtronic plc
Senseonics Holdings, Inc.
Roche Diagnostics
LifeScan, Inc.
Ascensia Diabetes Care
Tandem Diabetes Care, Inc.
Insulet Corporation
Ypsomed Holding AG
Johnson & Johnson
GlucoWise
Beta Bionics
Pear Therapeutics
Diasend
F. Hoffmann-La Roche AG
Novo Nordisk A/S
Glooko, Inc.

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY COMPONENT TYPE- MARKET ANALYSIS, 2019 - 2032

Transmitters and Receivers
Sensors

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

Non-invasive
Invasive

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Self-Monitoring Blood Glucose (SMBG) Systems
Continuous Blood Glucose Monitoring (CBGM) Systems

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

Type-1 Diabetes
Type-2 Diabetes

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

Institutional Sales
Retail Sales
Others

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Continuous Glucose Monitoring Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Continuous Glucose Monitoring Market Snippet by Component Type
- 2.1.2. Continuous Glucose Monitoring Market Snippet by Modality
- 2.1.3. Continuous Glucose Monitoring Market Snippet by Product Type
- 2.1.4. Continuous Glucose Monitoring Market Snippet by Patient Type
- 2.1.5. Continuous Glucose Monitoring Market Snippet by Distribution Channel
- 2.1.6. Continuous Glucose Monitoring Market Snippet by Country
- 2.1.7. Continuous Glucose Monitoring Market Snippet by Region
2.2. Competitive Insights

3. Continuous Glucose Monitoring Key Market Trends

3.1. Continuous Glucose Monitoring Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Continuous Glucose Monitoring Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Continuous Glucose Monitoring Market Opportunities
3.4. Continuous Glucose Monitoring Market Future Trends

4. Continuous Glucose Monitoring Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Continuous Glucose Monitoring Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Continuous Glucose Monitoring Market Landscape

6.1. Continuous Glucose Monitoring Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Continuous Glucose Monitoring Market - By Component Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Component Type, 2023 & 2032 (%)
- 7.1.2. Transmitters and Receivers
- 7.1.3. Sensors

8. Continuous Glucose Monitoring Market - By Modality

8.1. Overview
- 8.1.1. Segment Share Analysis, By Modality, 2023 & 2032 (%)
- 8.1.2. Non-invasive
- 8.1.3. Invasive

9. Continuous Glucose Monitoring Market - By Product Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
  - 9.1.1.1. Self-Monitoring Blood Glucose (SMBG) Systems
  - 9.1.1.2. Continuous Blood Glucose Monitoring (CBGM) Systems

10. Continuous Glucose Monitoring Market - By Patient Type

10.1. Overview
- 10.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
- 10.1.2. Type-1 Diabetes
- 10.1.3. Type-2 Diabetes

11. Continuous Glucose Monitoring Market - By Distribution Channel

11.1. Overview
- 11.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
- 11.1.2. Institutional Sales
- 11.1.3. Retail Sales
- 11.1.4. Others

12. Continuous Glucose Monitoring Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Continuous Glucose Monitoring Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.2.9. The U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Continuous Glucose Monitoring Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.10. Italy
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. Italy Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.10.5. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.10.6. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.10.7. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.11. United Kingdom
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. United Kingdom Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.11.5. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.11.6. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.11.7. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.12. France
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. France Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.12.5. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.12.6. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.12.7. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.13. Russia
  - 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.2. Russia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.13.3. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.14. Netherlands
  - 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.2. Netherlands Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.14.3. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.14.4. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.14.5. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.14.6. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.2. Sweden Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.16. Poland
  - 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.2. Poland Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.16.3. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.17. Rest of Europe
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Rest of the Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Continuous Glucose Monitoring Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.9. India
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. India Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.9.5. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.9.6. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.9.7. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.10. China
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. China Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.10.5. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.10.6. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.10.7. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.14. Thailand
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Thailand Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.15. Indonesia
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Indonesia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Continuous Glucose Monitoring Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Continuous Glucose Monitoring Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Continuous Glucose Monitoring Industry

13.1. Competitive Dashboard
- 13.1.1. Competitive Benchmarking
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Abbott Laboratories
- 13.2.2. Dexcom, Inc.
- 13.2.3. Medtronic plc
- 13.2.4. Senseonics Holdings, Inc.
- 13.2.5. Roche Diagnostics
- 13.2.6. LifeScan, Inc.
- 13.2.7. Ascensia Diabetes Care
- 13.2.8. Tandem Diabetes Care, Inc.
- 13.2.9. Insulet Corporation
- 13.2.10. Ypsomed Holding AG
- 13.2.11. Johnson & Johnson
- 13.2.12. GlucoWise
- 13.2.13. Beta Bionics
- 13.2.14. Pear Therapeutics
- 13.2.15. Diasend
- 13.2.16. F. Hoffmann-La Roche AG
- 13.2.17. Novo Nordisk A/S
- 13.2.18. Glooko, Inc.

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us